Crispr Therapeutics shares owned by Capital International
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital International
from 13F filings
Historical chart of Capital International investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital International consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Capital International
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.8M | 103k | 46.98 |
| 2024-03-31 | $6.2M | 92k | 68.16 |
| 2023-12-31 | $4.3M | 69k | 62.60 |
| 2023-09-30 | $3.1M | 68k | 45.39 |
| 2023-06-30 | $3.7M | 65k | 56.14 |
| 2023-03-31 | $2.8M | 61k | 45.23 |
| 2022-12-31 | $2.0M | 49k | 40.65 |
| 2022-09-30 | $3.5M | 53k | 65.35 |
| 2022-06-30 | $2.7M | 44k | 60.77 |
| 2022-03-31 | $2.3M | 36k | 62.77 |
| 2021-12-31 | $3.9M | 51k | 75.79 |
| 2021-09-30 | $5.5M | 49k | 111.92 |
| 2021-06-30 | $8.6M | 53k | 161.89 |
| 2021-03-31 | $8.6M | 71k | 121.85 |
| 2020-12-31 | $18M | 119k | 153.11 |
| 2020-09-30 | $9.3M | 112k | 83.64 |